NCT05765253View on ClinicalTrials.gov

Achieving Portal Access With Scorpion Post-Approval Study (APASS)

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

October 16, 2023

Study Completion Date

November 19, 2023

Conditions
Portal HypertensionLiver DiseasesAscites HepaticHydrothoraxVascular Diseases
Interventions
DEVICE

Scorpion Portal Vein Access Kit

Portal Vein Access with Scorpion or Scorpion X set

DEVICE

Cook Transjugular Liver Access Set

Portal Vein Access with Ring or Rosch-Uchida set

PROCEDURE

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Trial Locations (3)

10032

New York Presbyterian - Columbia University Medical Center, New York

27599

University of North Carolina at Chapel Hill, Chapel Hill

30322

Emory University, Atlanta

Sponsors

Collaborators (1)

Avania
All Listed Sponsors
collaborator

Avania

INDUSTRY

lead

Argon Medical Devices

INDUSTRY

NCT05765253 - Achieving Portal Access With Scorpion Post-Approval Study (APASS) | Biotech Hunter | Biotech Hunter